TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate

Published:2024-06 Issue:6 Volume:30 Page:743-754
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Hernández-Mitre María Patricia,Morpeth Susan C.,Venkatesh Balasubramanian,Hills Thomas E.,Davis Joshua,Mahar Robert K.,McPhee Grace,Jones Mark,Totterdell James,Tong Steven Y.C.,Roberts Jason A.

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Reference46 articles.

1. WHO COVID-19 dashboard,2020

2. Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents

3. Nafamostat mesilate;Okajima;Cardiovasc Drug Rev,1995

4. Pharmaceutical interview form for FUTHAN 10 INJ. FUTHAN 50 INJ,2019

5. Pharmaceutical interview form. Nafamostat mesylate,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate;Clinical Microbiology and Infection;2024-06

2. Progress in SARS-CoV-2, diagnostic and clinical treatment of COVID-19;Heliyon;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP